Citadel Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.7M	Buy	1,323,728 +942,838	+248%	+$15.6M	﹤0.01%	2077
2025 Q4	$5.02M	Buy	380,890 +331,556	+672%	+$3.91M	﹤0.01%	4283
2025 Q3	$354K	Sell	49,334 -1,624,707	-97%	-$84.7M	﹤0.01%	9970
2025 Q2	$79M	Buy	1,674,041 +195,406	+13%	+$7.96M	0.01%	915
2025 Q1	$57.8M	Sell	1,478,635 -708,231	-32%	-$30.5M	0.01%	1045
2024 Q4	$118M	Sell	2,186,866 -136,105	-6%	-$6.95M	0.02%	651
2024 Q3	$117M	Buy	2,322,971 +57,276	+3%	+$2.68M	0.02%	609
2024 Q2	$99.6M	Sell	2,265,695 -43,738	-2%	-$1.85M	0.02%	686
2024 Q1	$116M	Buy	2,309,433 +300,773	+15%	+$16.3M	0.02%	616
2023 Q4	$121M	Sell	2,008,660 -25,736	-1%	-$1.33M	0.02%	577
2023 Q3	$116M	Buy	2,034,396 +13,788	+0.7%	+$761K	0.02%	553
2023 Q2	$103M	Sell	2,020,608 -902,830	-31%	-$24.3M	0.02%	598
2023 Q1	$62.5M	Buy	2,923,438 +37,346	+1%	+$628K	0.01%	906
2022 Q4	$30.3M	Buy	2,886,092 +200,155	+7%	+$1.78M	0.01%	1545
2022 Q3	$21.4M	Sell	2,685,937 -16,724	-0.6%	-$118K	﹤0.01%	1806
2022 Q2	$13.9M	Buy	2,702,661 +2,003,765	+287%	+$12.6M	﹤0.01%	2267
2022 Q1	$7.76M	Buy	698,896 +12,959	+2%	+$129K	﹤0.01%	3381
2021 Q4	$6.6M	Hold	685,937	–	–	﹤0.01%	3817
2021 Q3	$6.77M	Sell	685,937 -5,794	-0.8%	-$57.8K	﹤0.01%	3742
2021 Q2	$7.15M	Sell	691,731 -1,636	-0.2%	-$16.6K	﹤0.01%	3703
2021 Q1	$7.07M	Buy	693,367 +6,289	+0.9%	+$69.3K	﹤0.01%	3558
2020 Q4	$7.44M	Buy	+687,078	New	+$7.29M	﹤0.01%	3051